tetradecanoylphorbol acetate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romero, Y; Wise, R; Zolkiewska, A | 1 |
| Gobe, GC; Morais, C; Song, W; Thakor, P; Vesey, DA | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells.
Topics: ADAM10 Protein; ADAM17 Protein; Amyloid Precursor Protein Secretases; B7-H1 Antigen; Cell Line, Tumor; Female; Humans; Ionomycin; Lymphocytes, Tumor-Infiltrating; Lysosomes; Membrane Proteins; Programmed Cell Death 1 Receptor; Proteolysis; Signal Transduction; Tetradecanoylphorbol Acetate; Triple Negative Breast Neoplasms | 2020 |
Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cellular Senescence; Culture Media, Conditioned; Cytokines; Female; Gene Expression Regulation, Neoplastic; Humans; Inflammation Mediators; Macrophage Activation; Macrophages; MCF-7 Cells; Paracrine Communication; Phenotype; Signal Transduction; Tetradecanoylphorbol Acetate; THP-1 Cells; Time Factors; Triple Negative Breast Neoplasms | 2018 |